The development of a nanotechnology enabled anti-viral face mask (NanoMask)

开发纳米技术抗病毒口罩（NanoMask）

• 批准号: 63429
• 金额: $ 6.36万
• 依托单位: PHARM 2 FARM LIMITED
• 依托单位国家: 英国
• 项目类别: Feasibility Studies
• 财政年份: 2020
• 资助国家: 英国
• 起止时间: 2020 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=63429
• 关键词: development; nanotechnology; enabled; anti; viral

A survey conducted by the British Medical Association found that half of doctors working in high risk environments do not have access to appropriate face masks. Also, the British Dental Association has lamented the typical UK dentist who can go through 250 face masks per week is now restricted to 100 no matter the practice size. A study by HSE and PHE on the use of PPE in health care settings published on the 27th of March recommended the use of FFP3 but if not available FFP2 and N95 masks can be used. However, there is no certified manufacturing of face masks in the UK and there is only one manufacturer of spunbond and meltblown nonwoven medical fabrics, a material used for FFP2/N95 disposable respirators.Pharm2Farm (Lead) and Flexotronix (subcontractor) aim to combine their leading nanotechnology capabilities to produce a highly enhanced anti-viral face mask to meet N95/FFP2 and FFP3 specifications.

英国医学协会进行的一项调查发现，在高风险环境中工作的医生中有一半无法获得适当的口罩。此外，英国牙科协会哀叹，无论诊所规模如何，每周可以使用250个口罩的典型英国牙医现在都被限制在100个。HSE和PHE于3月27日发布的一项关于医疗保健环境中个人防护装备使用的研究建议使用FFP 3，但如果没有FFP 2和N95口罩，也可以使用。然而，英国没有经过认证的口罩制造商，只有一家纺粘和熔喷非织造医用织物制造商，这种材料用于FFP 2/N95一次性口罩。Pharm 2Farm（牵头）和Flexotronix（分包商）旨在将其领先的纳米技术能力联合收割机结合起来，生产高度增强的抗病毒口罩，以满足N95/FFP 2和FFP 3规格。